✦ LIBER ✦

Implications of First-Line Adjuvant Treatment with Aromatase Inhibitors in Recurrent Metastatic Breast Cancer

✍ Scribed by Lisa E. Sokolowicz; William J. Gradishar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimising adjuvant endocrine treatment

✍ I. S. Fentiman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

First-line endocrine treatment of breast

✍ Wong, Z-W; Ellis, M J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

P319 Phase II study of high-dose toremif

✍ M. Sawaki; M. Wada; Y. Sato; Y. Mizuno; H. Kobayashi; K. Yokoi; M. Yoshihara; K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Breast Cancer in Men—Should Aromatase In

✍ Ina C. Nordman; David N. Dalley 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

Aromatase inhibitors in the treatment of

✍ Glück, Stefan; von Minckwitz, Gunter; Untch, Michael 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Systematic review of aromatase inhibitor

✍ Rob Riemsma; C. A. Forbes; A. Kessels; K. Lykopoulos; M. M. Amonkar; D. W. Rea; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 371 KB